BMS Submits EMA Application for Opdivo and Yervoy for mCRC
Bristol Myers Squibb (BMS) recently submitted an application to the European Medicines Agency (EMA) for the use of the...
Adaptive Clinical Trial Design Adaptive Trial Design AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies DOGE FDA Budget Cuts eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Authority FDA Regulatory Strategy GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Protocol Design Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
Bristol Myers Squibb (BMS) recently submitted an application to the European Medicines Agency (EMA) for the use of the...
Integrating Digital Health Technologies (DHTs) in drug development is revolutionizing clinical trials, especially with the rise of decentralized clinical...
Boehringer Ingelheim and Walgreens have joined forces to revolutionize clinical trials. Through this collaboration, people with obesity, overweight, and...
A promising new treatment option has emerged for patients with mantle cell lymphoma (MCL), a rare and aggressive type...
In this engaging interview with Jennifer Duff, General Manager, Zelta Clinical Trials Solutions at Merative, we explore technology’s pivotal...
The National Institutes of Health (NIH) has chosen Advarra as its exclusive single institutional review board (sIRB) for clinical...
Cambridge Cognition, a leader in digital brain health assessment solutions, and The Michael J. Fox Foundation for Parkinson’s Disease...
Remepy, a pioneer in “hybrid drugs,” has secured $15 million in funding, led by NFX and supported by several...
SecondWave Systems has made a breakthrough in the treatment of rheumatoid arthritisarthritis (RA) with their novel ultrasonic stimulation technology....
In an insightful discussion, Tom White, Chief Product Officer of Nye Health, highlights the company’s innovations in clinical trial...